Pharma-FDA collaboration can boost DTC as public health tool

07/15/2013 | Medical Marketing & Media

The FDA can make a difference in direct-to-consumer communications by working with the pharmaceutical industry, writes Peter Pitts, president of the Center for Medicine in the Public Interest and a former associate commissioner at the FDA. Both parties can transform DTC into a more persuasive, accurate and potent tool that will benefit public health, he writes.

View Full Article in:

Medical Marketing & Media

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
Bridgewater, NJ